Prescription drug · ANDA
Furosemide NDC 71872-7278
Furosemide 10 mg/mL · Injection · Intramuscular, Intravenous · Medical Purchasing Solutions, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71872-7278-1 | 71872727801 | 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7278-1) / 4 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 10, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Furosemide
- Generic name (nonproprietary)
- furosemide
- Active ingredients
- Furosemide — 10 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 070017
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis at Loop of Henle (Physiologic effect)
- Identifiers
- Product ID 71872-7278_facb5297-bc02-ea41-e053-6394a90a840cSPL ID facb5297-bc02-ea41-e053-6394a90a840cSPL set ID d8a064cc-c741-8b80-e053-2a95a90a364cRxCUI 1719291UNII 7LXU5N7ZO5
- Pharmacologic class
- Loop Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N471872727801followed by a unit qualifier and the quantityPackage 71872-7278-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. Edema: Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Furosemide is indicated as adjunctive therapy in acute pulmonary edema. The intravenous administration of furosemide is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema. If gastrointestinal absorption is impai…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 070017
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | Accord Healthcare, Inc. | 16729-500 |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | Accord Healthcare, Inc. | 16729-501 |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | Accord Healthcare, Inc. | 16729-502 |